What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Disease
His main research concerns Type 1 diabetes, Immunology, Internal medicine, Autoantibody and Diabetes mellitus.
His Type 1 diabetes study incorporates themes from Cohort study, Human leukocyte antigen, Insulin, Disease and Prospective cohort study.
His study explores the link between Immunology and topics such as Case-control study that cross with problems in Immunity and Genome-wide association study.
Olli Simell focuses mostly in the field of Internal medicine, narrowing it down to topics relating to Endocrinology and, in certain cases, Maternal effect and Ornithine.
His Autoantibody research is multidisciplinary, incorporating elements of Microbiome, Seroconversion, Enterovirus and Virology.
His Diabetes mellitus research includes themes of Predictive value of tests and Genetic predisposition.
His most cited work include:
- Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children (568 citations)
- Toward defining the autoimmune microbiome for type 1 diabetes (552 citations)
- Toward defining the autoimmune microbiome for type 1 diabetes (552 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Type 1 diabetes, Immunology, Endocrinology and Diabetes mellitus.
His Internal medicine study combines topics in areas such as Gastroenterology and Lysinuric protein intolerance.
His study in Type 1 diabetes is interdisciplinary in nature, drawing from both Autoantibody, Human leukocyte antigen, Insulin and Genotype.
His Immunology study is mostly concerned with Autoimmunity, Antibody, Autoimmune disease, Seroconversion and Immunopathology.
The Endocrinology study which covers Ornithine that intersects with Urea cycle.
The various areas that Olli Simell examines in his Diabetes mellitus study include Pregnancy and Genetic predisposition.
He most often published in these fields:
- Internal medicine (41.45%)
- Type 1 diabetes (43.82%)
- Immunology (38.00%)
What were the highlights of his more recent work (between 2013-2021)?
- Type 1 diabetes (43.82%)
- Immunology (38.00%)
- Internal medicine (41.45%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Type 1 diabetes, Immunology, Internal medicine, Autoimmunity and Autoantibody.
His Type 1 diabetes research is classified as research in Diabetes mellitus.
His Immunology study combines topics from a wide range of disciplines, such as Disease, Human bocavirus and Virology.
His Internal medicine research integrates issues from Gastroenterology and Endocrinology.
His Autoimmunity study deals with Islet intersecting with Human virome.
His Autoantibody research incorporates elements of FOXP3, Genome-wide association study and Immunity.
Between 2013 and 2021, his most popular works were:
- The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study. (205 citations)
- Coxsackievirus B1 Is Associated With Induction of β-Cell Autoimmunity That Portends Type 1 Diabetes (162 citations)
- Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes. (138 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Disease
Olli Simell spends much of his time researching Type 1 diabetes, Immunology, Autoantibody, Diabetes mellitus and The Environmental Determinants of Diabetes in the Young.
His Type 1 diabetes research includes elements of Internal medicine, Case-control study, Prospective cohort study, Seroconversion and Islet.
The Internal medicine study combines topics in areas such as Gastroenterology and Endocrinology.
Autoimmunity and Human leukocyte antigen are the subjects of his Immunology studies.
His biological study spans a wide range of topics, including PTPN22, Genome-wide association study, Incidence and Immunity.
Olli Simell has included themes like Physical therapy, Dietary counseling, Blood pressure and Cohort in his Diabetes mellitus study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
